Please assess the completion status of the following clinical trial:

Trial Title: Mifepristone Versus Laminaria Insertion for Cervical Preparation Prior to Surgical Abortion at 14-16 Weeks

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* women aged 18-45 having pregnancy termination at 14-16 weeks~Exclusion Criteria:~* multiple gestation, pre-existing infection, contraindication to osmotic dilators, unable to obtain proper consent

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 45 Years
- Healthy Volunteers: f

Study Arms:
- mifepristone (Type: EXPERIMENTAL): women in the mifepristone are would take mifepristone 200 mg for cervical preparation the day before their procedure, and not have dilators inserted. In this group, the sstandard procedure of osmotic dilator insertion is NOT performed.
- Osmotic dilator insertion (Type: ACTIVE_COMPARATOR): Women assigned to this arm would have the standard procedure for cervical preparation, which is insertion of osmotic dilators the day before the abortion procedure

Based on this trial design, predict the completion outcome and termination type (if applicable).